About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Chicago | 713 Studies

Clinical Trials Breast CancerChicago

Breast Cancer Clinical Trials in Chicago

Find 713 clinical trials for breast cancer near Chicago, Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 713 trials

CompletedA Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyThe purpose of this study is to assess the safety and efficacy of oral abiraterone acetate plus oral prednisone and oral abiraterone acetate plus oral prednisone plus oral…NCT01381874·Muscle Shoals, Alabama and 80 others

Breast Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast CancerThis phase II trial studies how well everolimus with or without trastuzumab works in treating patients with breast cancer that has not responded to hormone therapy and has spread…NCT00912340·Atlanta, Georgia and 3 others

CompletedCombination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004125·Birmingham, Alabama and 47 others

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

RecruitingPRE-ISPY Phase I/II Oncology Platform ProgramPRE-ISPY Phase I/II (I-SPY-P1) is an open-label, multisite platform study with multiple ongoing drug regimen arms added by protocol amendment which is designed to evaluate single…NCT05868226·Birmingham, Alabama and 9 others

Active not recruitingOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men…NCT06016738·Tucson, Arizona and 232 others

SuspendedTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialThis phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive…NCT06671912·Anchorage, Alaska and 731 others

UnknownEvaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaMARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluate IPI-549, Infinity Pharmaceutical's first-in-class, oral immuno-oncology product candidate targeting…NCT03961698·Chandler, Arizona and 23 others

CompletedDose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabThis clinical trial is a Phase 1/2, open-label, sequential-group, dose-escalation and cohort expansion study to determine the safety and preliminary anti-tumor activity of FLX475…NCT03674567·Gilbert, Arizona and 34 others

RecruitingStudy of XB010 in Subjects With Solid TumorsThis is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with…NCT06545331·Irvine, California and 19 others

Active not recruitingAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerThis phase II trial studies how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the combination of avelumab with sacituzumab govitecan…NCT03971409·Birmingham, Alabama and 11 others

Active not recruitingStudying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationThis phase III trial compares denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation.NCT04711109·Los Angeles, California and 46 others

CompletedCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004906·Chicago, Illinois and 3 others

Completed1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyThe study is being conducted to compare progression-free survival in patients treated with sorafenib and gemcitabine/capecitabine versus patients treated with placebo and…NCT00493636·Anchorage, Alaska and 43 others

CompletedSafety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenThis study is a randomized, double-blind, placebo-controlled, adaptive design, multi-center study of the long-term cardiovascular and breast safety of LibiGel in the treatment of…NCT00612742·Birmingham, Alabama and 148 others

CompletedMarimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyRATIONALE: Marimastat may stop the growth of breast cancer by stopping blood flow to the tumor.NCT00003010·Scottsdale, Arizona and 24 others

Active not recruitingHigher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryRATIONALE: It is not yet know whether higher per daily radiation therapy is equally as effective as standard per daily radiation therapy in treating breast cancer.NCT01349322·Birmingham, Alabama and 414 others

TerminatedTivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast CancerThis is a phase 2 multicenter, double-blind, randomized, placebo-controlled, two-arm study for subjects with locally recurrent or metastatic triple negative breast cancer.NCT01745367·Birmingham, Alabama and 53 others

TerminatedA Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery.NCT04752332·Glendale, Arizona and 114 others

CompletedPaclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryThis randomized phase III trial studies paclitaxel and trastuzumab with or without lapatinib to see how well they work in treating patients with stage II or stage III breast…NCT00770809·Tucson, Arizona and 317 others

PreviousPage 2 of 36Next

Other Conditions in Chicago

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma